Ohio State University College of Medicine Signs a Collaboration Agreement on Digital Pathology with BioImagene

Business Wire, May 10, 2005

SAN MATEO, Calif. -- The Ohio State University College of Medicine and BioImagene announced that they have signed an agreement to engage in numerous collaborative activities, including joint research proposals at the state and national levels, joint projects with profit potential, and other mutually beneficial activities. The collaborative program is to be undertaken by the Department of Pathology, under the leadership of Sanford H. Barsky, M.D., Professor and Senhauser Chair in the Department of Pathology, who has teamed up with BioImagene to develop Digital Pathology as both a research as well as a diagnostic tool.

"This collaboration combines the pathology experience of Ohio Sate and its unique patient database with the computer software imaging expertise of BioImagene to develop and validate imaging algorithms that can be applied to various areas of anatomical pathology, including tissue microarray interpretation, immunocytochemistry, in situ hybridization, and hematoxylin and eosin-based diagnosis," Dr. Barsky stated. "I am very excited about this collaboration because it brings together the pathological know-how and the digital imaging know-how to work in a synergistic fashion so that real progress can be made."

"In order to develop a comprehensive solution, we needed access to a vast number of tissue samples, clinical data, outcome data and the deep domain knowledge with the experts to validate our results. Collaboration with OSU gives us that strong base to better the cancer research and diagnostics, and could have a lasting impact on the industry. This is a win-win situation for all stakeholders -- OSU, BioImagene, industry, and community," said Mohan Uttarwar, President and CEO of BioImagene.

About The Ohio State University College of Medicine

The Ohio State University Medical Center includes the College of Medicine, five hospitals, two free-standing research institutes and a network of more than 30 community-based primary and specialty care facilities throughout central Ohio. The Department of Pathology has already advanced virtual slide imaging technology and has created a database of virtual slide images. OSU has an outstanding Department of Biomedical Informatics using the latest in computer grid technology. Together, this makes OSU a leading player on the national scene in digital pathology and medical bioinformatics.

About BioImagene

BioImagene provides sophisticated bio-image analysis products built on iHarness(TM), its proprietary technology platform. BioImagene's products allow pathologists and researchers to analyze and interpret images with far greater speed and consistency. The data management systems and web-based nature of BioImagene's technology facilitate collaboration, improving the standard of patient care and increasing the speed of drug discovery. Through its recent acquisition of Scimagix, Inc., BioImagene has expanded its product offerings of image informatics solutions. The company serves most of the top 15 pharmaceutical companies as well as major pathology reference laboratories. BioImagene is headquartered in San Mateo, California. For more information on BioImagene, visit www.bioimagene.com.